AVANIR Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Sep 08 | Sep 07 | Sep 06 | |
|---|---|---|---|
| Net Operating Cash Flow | (16.7) | (46.6) | (41.0) |
| Net Investing Cash Flow | 1.0 | 59.6 | (7.4) |
| Net Financing Cash Flow | 26.5 | 12.7 | 44.7 |
| Net Change in Cash | 10.9 | 25.6 | (3.7) |
| Depreciation & Amortization | 0.7 | 2.8 | 3.9 |
| Capital Expenditures | (0.1) | (0.1) | (1.7) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
